FACS analysis of mouse C57Bl/6 splenocytes using GTX01465-08 CD5 antibody [53-7.3] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.25 microg (5 microl)
FACS analysis of mouse C57Bl/6 splenocytes using GTX01465-08 CD5 antibody [53-7.3] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.25 microg (5 microl)
CD5 antibody [53-7.3] (PE)
GTX01465-08
Overview
- SupplierGeneTex
- Product NameCD5 antibody [53-7.3] (PE)
- Delivery Days Customer9
- Application Supplier Note*Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID53-7.3
- Concentration0.2 mg/ml
- ConjugateRPE
- Gene ID12507
- Target nameCd5
- Target descriptionCD5 antigen
- Target synonymsLy; Ly-; Ly-1; Ly-12; Ly-A; lymphocyte antigen 1; Lyt-; Lyt-1; T-cell surface glycoprotein CD5
- HostRat
- IsotypeIgG2a
- Protein IDP13379
- Protein NameT-cell surface glycoprotein CD5
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. Azzam HS et al., 1998 Dec 21, J Exp MedRead more
- A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. Bikah G et al., 1998 Aug, Int ImmunolRead more
- CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Bikah G et al., 1996 Dec 13, ScienceRead more
- A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Tarakhovsky A et al., 1995 Jul 28, ScienceRead more
- The Ly-1 B cell subpopulation in normal immunodefective, and autoimmune mice. Hayakawa K et al., 1983 Jan 1, J Exp MedRead more
- T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. Ledbetter JA et al., 1980 Aug 1, J Exp MedRead more